ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BBLGW Bone Biologics Corporation

41.62
8.12 (24.24%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -656k-501k-1.22M-1.29M-3.15M-3.04M-2.08M-1.16M
Pre Tax Income -656k-501k-1.22M891k-3.71M-1.77M-1.92M-1.55M
Net Income -689k-470k-1.22M893k-3.71M-1.77M-1.92M-1.55M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -656k-501k-1.22M-2.02M-3.15M-3.04M-2.08M-1.16M
EBITDA -656k-501k-1.22M-1.29M-3.15M-3.04M-2.08M-1.16M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -17.85M-2.63M-2.79M-2.45M-825k-1.1M-3.67M-9.43M
Pre Tax Income -21.03M-7.05M-4.43M-3.42M-1.82M-1.61M-1.49M-8.95M
Net Income -21.03M-7.05M-4.43M-3.43M-1.83M-1.61M-1.49M-8.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.542-0.163-0.167-0.112-0.059-0.156-0.097-2.855
EBIT -17.85M-2.63M-3.2M-2.45M-825k-1.1M-4.4M-9.43M
EBITDA -17.85M-2.63M-2.79M-2.45M-825k-1.1M-3.67M-9.43M

Your Recent History

Delayed Upgrade Clock